By integrating VoxCell’s high-resolution 3D bioprinted tissue platforms into Altasciences’ discovery and preclinical services, both companies aim to reduce R&D timelines and increase the success rate of investigational therapies. LAVAL,… Read More
VANCOUVER, BC – Kapoose Creek Bio is delighted to announce the appointment of Dr. Stewart Fisher to its Board of Directors. Globally recognized as a trailblazer in drug discovery and… Read More
VANCOUVER, BC – ARC Medical Inc., a clinical stage medical device company focused on advancing surgical adhesion prevention, announced that three scientific abstracts highlighting one of its lead medical devices,… Read More
Scemblix® is first to show superior efficacy and a favourable safety and tolerability profile in a Phase III trial vs. all standard of care (SoC) therapies Fifty percent of CML… Read More
Final CDA recommendation reflects the urgent unmet need in a progressive, life-limiting condition and recognizes the value of a therapy that slows disease progression Regional differences in disease burden make… Read More
